0001171843-26-003487
SEC filingPOET Technologies reported Q1 2026 non-recurring engineering and product revenue of $503,389 with a net loss of $12.3 million, alongside a $50 million purchase order from Lumilens and key AI partnerships.
POET Technologies' Q1 2026 results reflect a transition from technology development to product commercialization, with non-recurring engineering and product revenue tripling year-over-year to $503,389, driven by demand for its Optical Interposer platform in AI and data center applications. The net loss of $12.3 million, or $0.08 per share, contrasts sharply with Q1 2025's $6.3 million net income, primarily due to the absence of a $15.4 million non-cash gain on derivative warrant liability that boosted prior results; this quarter featured a smaller $1.6 million gain. Elevated stock-based compensation at $3.4 million (up from $0.8 million YoY) and steady R&D spend of $4.5 million underscore investments in scaling production and product roadmap. CEO Dr. Suresh Venkatesan highlighted progress in AI ecosystem positioning via partnerships with LITEON, Lessengers, and Lumilens, the latter securing a landmark $50 million purchase order for EOI-based engines as the first phase of a potential $500+ million five-year relationship. Joint development of 1.6T transceivers with Lessengers and LITEON collaborations for next-gen modules signal revenue acceleration potential. The planned U.S. domiciliation aims to resolve PFIC status, enhancing investor appeal. Operating cash burn remained stable at $8.8 million, aligning with growth-stage dynamics amid accelerating AI infrastructure demand.